CathWorks Unveils Key Events for EuroPCR 2025
CathWorks, a prominent player in digital health innovations, has announced an exciting lineup of events for the upcoming EuroPCR 2025 conference scheduled for May 20 to 23 at the Palais des Congrès. This conference is set to showcase advancements in cardiovascular care, and CathWorks is poised to make a significant impact with its presentations and educational sessions.
Scientific Presentations at EuroPCR 2025
Among the highlights, Dr. Toru Tanigaki from Gifu Heart Center will present the findings from the landmark PROVISION study. This study examines the one-year outcomes comparing the revolutionary FFRangio guidance with traditional invasive pressure wire methods. Collectively, these insights will shed light on the advantages of non-invasive measures in improving patient care.
Educational Symposium: Advancing Patient Care
The educational symposium titled The New Global Era of Patient Care with CathWorks FFRangio will take place during the lunch hours on Thursday. This session will feature Dr. Rasha Al-Lamee and Professor Ran Kornowski leading discussions geared toward integrating CathWorks FFRangio technology into clinical practice.
During this symposium, an esteemed panel of experts, including Dr. Benjamin Honton, Dr. Thomas Keeble, Dr. Stephane Fournier, and Professor Hitoshi Matsuo, will share their insights on the successful adoption of the FFRangio System in various healthcare settings, highlighting its role in transforming cardiovascular diagnostics.
FFRangio System Demonstrations
Participants will have the chance to experience hands-on demonstrations of the FFRangio System throughout the conference. Meet the Expert sessions will provide an invaluable opportunity for attendees to engage with leading physicians discussing the practical applications of this innovative technology.
Commitment to Improving Patient Outcomes
Ramin Mousavi, President and CEO of CathWorks, expressed enthusiasm about their collaboration with Medtronic, which has accelerated the adoption of the FFRangio System in catheterization labs worldwide. "Our partnership has been vital for our growth and integration within the interventional cardiology community. We are committed to making FFRangio the global standard for patient care," said Mousavi.
About CathWorks
CathWorks is renowned for leading digital health innovations aimed at enhancing patient outcomes. The FFRangio System employs artificial intelligence and advanced computational science to transform the way cardiovascular diseases are diagnosed and treated, obtaining essential physiological information from standard angiograms without the need for invasive procedures.
Investors and stakeholders interested in CathWorks can find further information on their practices and innovations at www.cath.works or follow them on social media platforms to stay updated on the latest developments in cardiovascular healthcare.
Frequently Asked Questions
What is EuroPCR 2025?
EuroPCR 2025 is a conference focused on advancements in cardiovascular medicine and technology held annually.
What is the FFRangio System?
The FFRangio System is an innovative technology that uses artificial intelligence to analyze physiologic data from angiograms, improving diagnosis and treatment.
Who are the key presenters at EuroPCR 2025?
Dr. Toru Tanigaki and Dr. Rasha Al-Lamee are among the notable presenters, discussing critical studies and innovations.
What is the aim of the educational symposium?
The symposium aims to discuss the integration of the FFRangio System into clinical settings and its impact on patient care.
How can I learn more about CathWorks?
More information is available on their website at www.cath.works.
